USPH Q4 2025 Earnings Call Summary | Stock Taper
Logo
USPH

USPH — U.S. Physical Therapy, Inc.

NYSE


Q4 2025 Earnings Call Summary

February 26, 2026

U.S. Physical Therapy, Inc. (USPH) Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

  • Revenue: Physical therapy revenues reached $168.3 million, a 17.3% increase year-over-year, primarily driven by acquisitions, notably the Metro acquisition.
  • Visits per Clinic: Average visits per clinic per day were 32.7, up from 30.6 in Q4 2024, marking a record for the company.
  • Adjusted EBITDA: Increased to $26.9 million, up $4.7 million from the prior year, with an adjusted EBITDA margin of 17.5%.
  • Gross Profit Margin: Improved to 21.1%, up from 20.1% in the same quarter last year.
  • Net Rate per Patient Visit: Slightly increased to $105.33, despite a 2.9% Medicare rate reduction.
  • Operating Costs: Total operating costs per visit decreased year-over-year, with salaries and related costs up only 0.7%.

2. Strategic Updates and Business Highlights:

  • The company is focusing on expanding its injury prevention partnerships, which saw a revenue increase of 22.6% and gross profit growth of 25.8%.
  • USPH has added over 50 net clinics compared to the prior year and reported over 3 million visits year-to-date.
  • The implementation of AI tools for clinical documentation is underway, aimed at improving efficiency and reducing clinician workload.
  • A share repurchase program was authorized for up to $25 million, reflecting management's confidence in the company's value.

3. Forward Guidance and Outlook:

  • USPH raised its full-year 2025 adjusted EBITDA guidance to a range of $93 million to $97 million, up from the previous range of $88 million to $93 million.
  • The company expects continued strong performance in the second half of the year, bolstered by ongoing initiatives and market demand.

4. Bad News, Challenges, or Points of Concern:

  • The company faces ongoing headwinds from Medicare reimbursement cuts, which have cumulatively impacted profits by approximately $25 million.
  • Same-store growth in mature facilities was lower than expected, with growth just over 1%, attributed to staffing challenges and cost management.
  • The labor market remains competitive, posing challenges in recruiting and retaining qualified staff, although turnover rates are currently at their lowest in seven years.

5. Notable Q&A Insights:

  • Management acknowledged solid demand for services but noted the need to balance staffing and cost control.
  • There is optimism regarding the potential for de novo clinic openings, with plans to enhance recruitment efforts through partnerships with educational institutions.
  • Discussions around Medicare rate increases for 2026 suggest a potential positive impact of $2 million to $3 million on revenue, though the final ruling is pending.
  • The company is exploring partnerships with virtual PT applications but remains cautious about the effectiveness of low-cost, non-clinician delivered services.

Overall, USPH reported a strong quarter with significant growth metrics, strategic initiatives in place, and a positive outlook, despite facing challenges from reimbursement pressures and staffing constraints.